Patent Assignment
Reel/Frame 069476/0103
Release of Security Interests
Recorded: 2024-12-03
Pages: 7
Assignor
ACQUIOM AGENCY SERVICES, LLC, AS COLLATERAL AGENT
Executed: 2024-11-29
Assignees
MALLINCKRODT PHARMA IP TRADING LIMITED
COLLEGE BUSINESS & TECHNOLOGY PARK CRUISERATH, BLANCHARDSTOWN, DUBLIN, 15, IRELAND
STRATATECH CORPORATION
510 CHARMANY DR # 169, MADISON, WISCONSIN, 53719
MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
COLLEGE BUSINESS & TECHNOLOGY PARK CRUISERATH, BLANCHARDSTOWN, DUBLIN, 15, IRELAND
Covered Properties
(23)
Method and Apparatus for the Continuous Separation of Biological Fluids into Components
Method for Collecting a Desired Blood Component and Performing a Photopheresis Treatment
Method and Apparatus for Collecting a Blood Component and Performing a Photopheresis Treatment
Phototherapy Compositions and Methods
Apparatus for the Continuous Separation of Biological Fluids into Components and Method of Using Same
Use of Apoptotic Cells Ex Vivo to Generate Regulatory T Cells
Method for Collecting a Desired Blood Component and Performing a Photopheresis Treatment
Phototherapy Compositions and Methods
Use of Apoptotic Cells Ex Vivo to Generate Regulatory T Cells
Centrifuge System and Method with Component Tracking
Patent:
10,434,239 →
Application:
15/261,968 →
Support for Centrifuge Tubing
Devices, Methods, and Systems for Priming, Separating, and Collecting Blood Components
Processing Blood
Method for Ex-Vivo Expansion of Regulatory T Cells with Enhanced Suppressive Function for Clinical Application in Immune Mediated Diseases
Use of Apoptotic Cells Ex Vivo to Generate Regulatory T Cells
Processing Blood
Processing Blood
Centrifuge System and Method with Component Tracking
Patent:
11,020,522 →
Application:
16/537,103 →
Devices, Methods, and Systems for Priming, Separating, and Collecting Blood Components
Processing Blood
Use of Apoptotic Cells Ex Vivo to Generate Regulatory T Cells
Application:
17/458,206 →
Publication:
US 2021/0388318
Method for Generating Immunoregulatory Cells in a Blood-Derived Sample
Method of Extracorporeal Photopheresis for Immune-Related Adverse Events
Application:
18/103,202 →
Publication:
US 2023/0165961
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jul 6, 2018
From: BRIGGS, DENNIS; DO, SIMON; VANDLIK, MARK; MURPHY, KEVIN
To: MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED
Reel/Frame 046280/0436 →
Nunc Pro Tunc Assignment
Jul 1, 2019
From: THERAKOS, INC.
To: MALLINCKRODT CRITICAL CARE FINANCE INC.
Reel/Frame 049643/0168 →
Nunc Pro Tunc Assignment
Jul 1, 2019
From: MALLINCKRODT CRITICAL CARE FINANCE INC.
To: MALLINCKRODT PHARMA IP TRADING D.A.C.
Reel/Frame 049643/0282 →
Nunc Pro Tunc Assignment
Jul 1, 2019
From: MALLINCKRODT PHARMA IP TRADING D.A.C.
To: MALLINCKRODT IP
Reel/Frame 049643/0348 →
Nunc Pro Tunc Assignment
Jul 1, 2019
From: MALLINCKRODT IP
To: MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED
Reel/Frame 049643/0397 →
Notice of Grant of Security Interest in Intellectual Property
Jul 22, 2019
From: MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 049822/0674 →
Nunc Pro Tunc Assignment
Aug 14, 2019
From: MALLINCKRODT PHARMA IP TRADING D.A.C.
To: MALLINCKRODT IP
Reel/Frame 050056/0219 →
Nunc Pro Tunc Assignment
Aug 14, 2019
From: MALLINCKRODT IP
To: MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED
Reel/Frame 050056/0303 →
Nunc Pro Tunc Assignment
Aug 14, 2019
From: MALLINCKRODT CRITICAL CARE FINANCE INC.
To: MALLINCKRODT PHARMA IP TRADING D.A.C.
Reel/Frame 050056/0122 →
Nunc Pro Tunc Assignment
Aug 14, 2019
From: THERAKOS, INC.
To: MALLINCKRODT CRITICAL CARE FINANCE INC.
Reel/Frame 050056/0042 →
Nunc Pro Tunc Assignment
Aug 15, 2019
From: MALLINCKRODT IP
To: MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED
Reel/Frame 050061/0605 →
Nunc Pro Tunc Assignment
Aug 15, 2019
From: MALLINCKRODT CRITICAL CARE FINANCE INC
To: MALLINCKRODT PHARMA IP TRADING D.A.C.
Reel/Frame 050061/0438 →
Nunc Pro Tunc Assignment
Aug 15, 2019
From: MALLINCKRODT PHARMA IP TRADING D.A.C.
To: MALLINCKRODT IP
Reel/Frame 050061/0498 →
Nunc Pro Tunc Assignment
Aug 15, 2019
From: THERAKOS, INC
To: MALLINCKRODT CRITICAL CARE FINANCE INC.
Reel/Frame 050061/0371 →
Security Interest
Dec 10, 2019
From: MALLINCKRODT ARD IP LIMITED; MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED; SPECGX LLC; OCERA THERAPEUTICS, INC.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
Reel/Frame 051256/0829 →
Assignment of Assignor's Interest
Jun 3, 2021
From: MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY
To: MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
Reel/Frame 056433/0640 →
Change of Name
Jun 3, 2021
From: MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED
To: MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY
Reel/Frame 056476/0162 →
Security Interest
Jun 17, 2022
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
Reel/Frame 060389/0913 →
Release of Security Interest
Jun 17, 2022
From: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
To: OCERA THERAPEUTICS, INC.; MALLINCKRODT LLC; MALLINCKRODT ARD IP UNLIMITED COMPANY (F/K/A MALLINCKRODT ARD IP LIMITED); MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY (F/K/A MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED)
Reel/Frame 060389/0839 →
Notice of Grant of Security Interest in Intellectual Property
Jun 22, 2022
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.
To: DEUTSCHE BANK AG NEW YORK BRANCH
Reel/Frame 060434/0536 →
Release of Security Interests in Patents at Reel 060389/Frame 0913
Nov 15, 2023
From: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
To: OCERA THERAPEUTICS LLC (F/K/A OCERA THERAPEUTICS, INC.); MALLINCKRODT LLC; MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY
Reel/Frame 065583/0465 →
Security Interest
Nov 15, 2023
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
To: ACQUIOM AGENCY SERVICES LLC
Reel/Frame 065595/0376 →
Release of Patent Security Interests Recorded at Reel 036662, Frame 0053
Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS LLC (F/K/A MALLINCKRODT US HOLDINGS INC.)
Reel/Frame 065610/0503 →
Release of Patent Security Interests Recorded at Reel 049822, Frame 0674
Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS LLC (F/K/A MALLINCKRODT US HOLDINGS INC.)
Reel/Frame 065609/0454 →
Release of Patent Security Interests Recorded at Reel 060434, Frame 0536
Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.
Reel/Frame 065601/0347 →